ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Health Technology

Chugai Pharmaceutical Co., Ltd.

Business Summary

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Financial Highlights

Dec 2020 JPYUSD
Revenue786,945M7,370.57M
Gross Profit511,775M4,793.31M
Operating income306,882M2,874.27M
Income before tax298,188M2,792.84M
Net income214,733M2,011.20M
EBITDA337,358M3,159.71M
Diluted EPS130.531.22
Dividends Per Share54.990.51
Total Assets1,235.49B11,966.66M
Total liabilities255,494M2,474.63M
Total equity980,003M9,492.01M
Operating cash flow205,101M1,920.98M
Currency in JPYCurrency in USD

Historical Data

 Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020
Revenue 491,780M 534,199M 579,787M 686,184M 786,945M
Gross Profit 243,553M 279,574M 316,025M 419,922M 511,775M
Operating income 79,320M 102,973M 129,225M 214,513M 306,882M
Income before tax 74,448M 97,031M 121,449M 207,893M 298,188M
Net income 53,592M 72,714M 92,488M 157,560M 214,733M
EBITDA 95,689M 119,307M 145,803M 240,914M 337,358M
Diluted EPS 32.65 44.27 56.26 95.80 130.53
Dividends Per Share 17.33 20.66 28.66 46.66 54.99
Total Assets 806,285M 852,473M 919,548M 1,058.91B 1,235.49B
Total liabilities 159,789M 159,576M 163,020M 204,929M 255,494M
Total equity 645,508M 691,924M 755,865M 853,985M 980,003M
Operating cash flow 39,080M 107,889M 119,269M 206,811M 205,101M
 Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020
Revenue 4,525.90M 4,763.94M 5,249.65M 6,294.64M 7,370.57M
Gross Profit 2,241.44M 2,493.22M 2,861.43M 3,852.11M 4,793.31M
Operating income 729.99M 918.30M 1,170.06M 1,967.81M 2,874.27M
Income before tax 685.15M 865.31M 1,099.65M 1,907.08M 2,792.84M
Net income 493.21M 648.45M 837.42M 1,445.36M 2,011.20M
EBITDA 880.63M 1,063.97M 1,320.16M 2,210.00M 3,159.71M
Diluted EPS 0.30 0.39 0.50 0.87 1.22
Dividends Per Share 0.15 0.18 0.25 0.42 0.51
Total Assets 6,912.89M 7,567.44M 8,381.24M 9,743.86M 11,966.66M
Total liabilities 1,369.99M 1,416.56M 1,485.84M 1,885.70M 2,474.63M
Total equity 5,534.42M 6,142.24M 6,889.34M 7,858.15M 9,492.01M
Operating cash flow 359.65M 962.14M 1,079.91M 1,897.16M 1,920.98M

Valuation Measures

Dec 2020
PER42.11
ROA18.71%
ROE23.41%
Operating margin38.99%
Profit margin27.28%

Key executives

  • Chairman & Chief Executive Officer: Tatsuro Kosaka
  • President, COO & Representative Director: Osamu Okuda
  • CFO, Manager-Information Technology & Accounting: Itagaki Toshiaki
  • Executive Officer, GM-Research & Development: Junichi Nezu
  • Senior Executive Officer & Head-Research: Hisafumi Okabe

Shareholders

  • Roche Holding AG (59.8%)
  • Nomura Asset Management Co., Ltd. (3.1%)
  • Chugai Pharmaceutical Co., Ltd. (2.0%)
  • Daiwa Asset Management Co. Ltd. (1.5%)
  • Nikko Asset Management Co., Ltd. (1.4%)
  • Capital Research & Management Co. (World Investors) (1.1%)
  • The Vanguard Group, Inc. (1.0%)
  • BlackRock Fund Advisors (0.8%)
  • Mitsubishi UFJ Kokusai Asset Management Co., Ltd. (0.7%)
  • Wellington Management Co. LLP (0.6%)

Contact Details

  • Website:http://www.chugai-pharm.co.jp
  • Address: Nihonbashi Mitsui Tower, 15/F, 2-1-1 Nihonbashi-Muromachi, Tokyo, 103-8324, Japan
  • Phone: +81.3.3281.6611

Related Companies

  • Chugai Pharma Europe Logistics SAS
  • Chugai Pharma Germany GmbH
  • Chugai Distribution Co., Ltd.
  • Medical Culture YK
  • Chugai Business Support Co., Ltd.
  • Chugai Clinical Research Center Co., Ltd.
  • Chugai Pharma Technology Taizhou Co., Ltd.
  • Chugai Pharmaceutical Restricted Stock Compensation Plan
  • Chugai Pharma Consulting (Shanghai) Co., Ltd.
  • Chugai Pharma R&D Taiwan Ltd.
  • Chugai Pharma China Co., Ltd.
  • Chugai Pharma Science (Beijing) Co., Ltd.
  • Chugai Pharma Taiwan Ltd.
  • Chugai Pharmabody Research Pte Ltd.
  • Pharmalogicals Research Pte Ltd.
  • Forerunner Pharma Research Co., Ltd.
  • Chugai Research Institute for Medical Science, Inc.
  • Chugai Pharma Manufacturing Co., Ltd.
  • Chugai Pharmaceutical Employee Stock Ownership Plan
  • Chugai Pharma U.K. Ltd.
  • Chugai Pharma France SAS
  • Chugai Biopharmaceuticals, Inc.
  • Chugai Pharma USA LLC
  • Nippon Roche KK

Competitors

  • Regeneron Pharmaceuticals, Inc.
  • Apellis Pharmaceuticals, Inc.
  • Harpoon Therapeutics, Inc.
  • BridgeBio Pharma, Inc.
  • Ascendis Pharma A/S Sponsored ADR
  • Springworks Therapeutics, Inc.
  • Cara Therapeutics Inc
  • Entera Bio Ltd.
  • InflaRx N.V.
  • Kiniksa Pharmaceuticals Ltd. Class A
Last Updated on 2 Dec, 2021

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more